Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.
D000212:Acyclovir / Q000627:therapeutic use; D000328:Adult; D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006558:Herpes Genitalis / Q000188:drug therapy*; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007251:Influenza, Human / Q000188:drug therapy; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D008297:Male; D010850:Picornaviridae Infections / Q000188:drug therapy; D012008:Recurrence; D012136:Respiratory Syncytial Viruses; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D010253:Respirovirus Infections / Q000188:drug therapy; D012229:Rhinovirus; D012254:Ribavirin / Q000627:therapeutic use; D012299:Rimantadine / Q000627:therapeutic use; D014271:Trifluridine / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use
D000998:Antiviral Agents; D012299:Rimantadine; D012254:Ribavirin; D000547:Amantadine; D014740:Vidarabine; D007065:Idoxuridine; D014271:Trifluridine; D000212:Acyclovir